Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion
about
A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serumAdvances in targeted proteomics and applications to biomedical researchCreation of a federated database of blood proteins: a powerful new tool for finding and characterizing biomarkers in serum.Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods.Sensitive targeted quantification of ERK phosphorylation dynamics and stoichiometry in human cells without affinity enrichment.The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.Long-gradient separations coupled with selected reaction monitoring for highly sensitive, large scale targeted protein quantification in a single analysis.Personalized Proteomics: The Future of Precision Medicine.A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.Microfluidic chip-based liquid chromatography coupled to mass spectrometry for determination of small molecules in bioanalytical applications: an update.Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.Mass spectrometry-based plasma proteomics: state of the art and future outlook.Quantitation of human peptides and proteins via MS: review of analytically validated assays.Applications of low-flow LC-SRM for the analysis of large molecules in pharmaceutical R&D.Current trends in magnetic particle enrichment for mass spectrometry-based analysis of cardiovascular protein biomarkers.Antibody-free workflows for protein quantification by LC-MS/MS.Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.Effects of calibration approaches on the accuracy for LC-MS targeted quantification of therapeutic protein.Clinical applications of MS-based protein quantification.Clinical translation of MS-based, quantitative plasma proteomics: status, challenges, requirements, and potential.Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsMultiple Reaction Monitoring Enables Precise Quantification of 97 Proteins in Dried Blood Spots.Deep-Dive Targeted Quantification for Ultrasensitive Analysis of Proteins in Nondepleted Human Blood Plasma/Serum and Tissues.Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins.Sensitive, High-Throughput, and Robust Trapping-Micro-LC-MS Strategy for the Quantification of Biomarkers and Antibody Biotherapeutics.High-throughput serum proteomics for the identification of protein biomarkers of mortality in older men.An enzyme-linked immuno-mass spectrometric assay with the substrate adenosine monophosphate.Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers.A simple dual online ultra-high pressure liquid chromatography system (sDO-UHPLC) for high throughput proteome analysis.Facile carrier-assisted targeted mass spectrometric approach for proteomic analysis of low numbers of mammalian cells
P2860
Q24307894-7FE069C7-9E1A-4A12-A61A-90A1825DCB79Q28066912-E4FABFDF-D70A-4EDF-A6A2-C97A4585C0F2Q33589680-C0915287-EB35-48FB-B2AC-54739BBF69E1Q35125405-26623259-7930-4B6D-B22F-CD3B7DF6D23CQ35193821-4863F704-1A31-442C-90A1-7E44398E68DDQ36771005-24C2BB52-5A2B-4E4A-9B2C-BC104DE0168CQ37341145-C28A3F0F-E3D8-4149-A8DF-36103C23DDD4Q37426540-6477AF55-32AA-4850-9DFC-165C7A20CFE7Q37651691-54203122-FAD3-4E26-B80E-330DB87E4846Q38156035-22E95C81-6ACA-4F2B-9ACC-435451A2CBFFQ38160931-263DE6B7-2111-4CC5-A193-AB0AC5569408Q38198753-DD29BFD2-3367-4EBE-99AE-306E83E015EFQ38243345-7251C604-AD29-4011-967A-9117AA4BB5D1Q38243346-169232D0-2C96-4F8C-BF4F-FC1C0C451973Q38364469-4930604F-2EC4-45F4-8562-195F0F5F4370Q38420122-BB2F5058-7CBB-45B8-90F3-807975B593EAQ38604366-0EA9812E-3C90-4908-8E81-9A9118305AFEQ38699577-5D45068A-40E9-4EB3-97F7-1FB80A531296Q38802991-1560B16E-2511-492E-BB9E-8E65BD4F4B32Q39657160-751BD958-A9F7-4AAF-A552-0713C123161EQ41414462-FCEF7B3E-C152-4BB8-BE5D-4975266E8F14Q42183242-075C27DB-D00B-49FE-BE19-E8CE829C30E6Q42279966-FD63D214-0BC4-41C7-A221-71F091CC906DQ47136739-DAE92B89-5B28-4748-B37A-C0322E3C883CQ47256369-6D9710FB-650D-4E65-BBB5-42C7DDD70947Q48107682-0BCCF44B-3828-441A-8AB2-B2F1F653B877Q51068513-41E862DC-BB0A-49EB-88F7-66B63DB84185Q52354794-1D5381BC-BF0E-45CF-8D7E-0E7F2CC8FF36Q53208198-164173C2-7610-46C2-92E3-A33A44DC5093Q57134955-E4BC3FA5-24DB-4B61-AD06-0E4301C71646
P2860
Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted quantification of low ...... thout immunoaffinity depletion
@en
Targeted quantification of low ...... hout immunoaffinity depletion.
@nl
type
label
Targeted quantification of low ...... thout immunoaffinity depletion
@en
Targeted quantification of low ...... hout immunoaffinity depletion.
@nl
prefLabel
Targeted quantification of low ...... thout immunoaffinity depletion
@en
Targeted quantification of low ...... hout immunoaffinity depletion.
@nl
P2093
P2860
P50
P356
P1476
Targeted quantification of low ...... thout immunoaffinity depletion
@en
P2093
Alvin Y Liu
David G Camp
Jacob Kagan
Jintang He
Karin D Rodland
Ronald J Moore
Thomas L Fillmore
P2860
P304
P356
10.1021/PR400178V
P577
2013-06-13T00:00:00Z